Home

FHM V, LP

CIK 1346948 · last filed 2017-02-06

FHM V, LP is a corporate insider who has filed 17 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider exercised options on $3.7M of ANAB on Feb 6, 2017. Across all open-market trades the lifetime net is +$478.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $125.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$125.75M

Companies

6

Total Filings

17

Lifetime Open-Market Net

$478.54M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANAB 10%+ Owner 2,345,612 $53.61 $125.75M $0 1 2017-02-06
Zeltiq Aesthetics Inc (ZLTQ) Delisted 10%+ Owner 4,427,244 — — $0 2 2013-09-24
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted 10%+ Owner 109,411 $6.22 $680.5K $14.64M 2 2009-02-26
CADENCE PHARMACEUTICALS INC (CADX) Delisted 10%+ Owner 7,848,501 — — $446.09M 1 2009-02-20
AMICUS THERAPEUTICS, INC. (FOLD) Delisted 10%+ Owner 767,618 $14.49 $11.12M $14.62M 8 2008-03-05
ENDOCARE INC (ENDO) Delisted 10%+ Owner 1,716,331 — — $3.19M 3 2008-01-31

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-02-06 ANAB Exer (X) +820,645 $3.73M EDGAR
2013-09-24 Zeltiq Aesthetics Inc (ZLTQ) Delisted Other (J) −13,281,732 $0 EDGAR
2013-08-08 Zeltiq Aesthetics Inc (ZLTQ) Delisted Other (J) −6,000,000 $0 EDGAR
2009-02-26 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Sell (S) −4,986,000 -$362.5K EDGAR
2009-02-20 CADENCE PHARMACEUTICALS INC (CADX) Delisted Buy (P) +62,565,156 $446.09M EDGAR
2008-03-05 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Buy (P) +262,044 $2.53M EDGAR
2008-02-25 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Buy (P) +39,684 $391.3K EDGAR
2008-02-20 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Buy (P) +297,000 $2.86M EDGAR
2008-02-07 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Buy (P) +272,862 $2.76M EDGAR
2008-02-04 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Buy (P) +114,425 $1.14M EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.